🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 23254L405 (prev. 23254L405 )
- Market Cap
- Micro Cap
- Previous Symbol
- CYCC (changed 9/12/2025)
- Previous Name
- Cyclacel Pharmaceuticals, Inc.
Business: Bio Green Med Solution, Inc. is a diversified company engaged in both the fire protection and biopharmaceutical industries.
Notes: July 02, 2025 -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today announced that it expects to implement a 1-for-15 reverse stock split on its shares of common stock effective July 7, 2025, with trading to begin on a split-adjusted basis at the market open on that day. Trading in the shares of common stock will continue on The Nasdaq Capital Market under the symbol “CYCC”. The new CUSIP number for the shares of common stock following the reverse stock split is 23254L876. <p> May 31, 2016 -- Cyclacel Pharmaceuticals, Inc. (CYCC) will effect a one-for-twelve (1-12) reverse split and the CUSIP number will change to 23254L405._______________August 27, 2012, 1-for-7 reverse stock split.
Company Contact
- CEO
- Datuk Dr. Doris Wong Sing Ee
- CFO
- Kiu Cu Seng
- Phone
- 908-517-7330
- Fax
- 866-271-3466
- Investor Relations
- Paul McBarron · 908-517-7330 · pmcbarron@cyclacel.com